An increased risk of breast cancer in women with a family history of breast cancer has been
demonstrated by many studies using a variety of study designs. However, the extent of this …

A key challenge in radiotherapy is to maximize radiation doses to cancer cells while minimizing
damage to surrounding healthy tissue. As severe toxicity in a minority of patients limits …

The normal functioning of p53 is a potent barrier to cancer. Tumour-associated mutations in
TP53, typically single nucleotide substitutions in the coding sequence, are a hallmark of …

Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer,
but the average magnitude of these risks is uncertain and may depend on the context. …

Breast cancer exhibits familial aggregation, consistent with variation in genetic susceptibility
to the disease. Known susceptibility genes account for less than 25% of the familial risk of …

Prostate cancer is the most frequently diagnosed cancer in males in developed countries.
To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a …

The knowledge of human genetic variation that will come from the human genome sequence
makes feasible a polygenic approach to disease prevention, in which it will be possible to …

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

Age at menarche is a marker of timing of puberty in females. It varies widely between
individuals, is a heritable trait and is associated with risks for obesity, type 2 diabetes, …

BACKGROUND & AIMS:: Germline mutations in CDH1 are known to cause hereditary diffuse
gastric cancer (HDGC). Breast and colorectal cancer have also been reported in C131-11-…